Malaria DNA vaccine - Roche
Latest Information Update: 13 Mar 1999
At a glance
- Originator Roche
- Class Antimalarials; DNA vaccines; Gene therapies; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Falciparum malaria
Most Recent Events
- 12 Mar 1999 New profile, split from generic Malaria vaccine profile
- 12 Mar 1999 Discontinued-I for Falciparum malaria in Switzerland (Unknown route)